Tainted Allergy Drug Recalled

Friday, 30 May 2014 12:06 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

Indian drugmaker Zydus Cadila is recalling 10,200 bottles of an allergy-relief drug in the United States after another drug for high blood pressure was found in one of the bottles, the U.S. Food and Drug Administration said on Friday.
 
The recall was voluntarily started by the company's U.S. unit, Zydus Pharmaceuticals USA Inc, on May 8, due to the presence of the high blood pressure medicine atenolol in a bottle containing the allergy drug, promethazine hydrochloride.
 
Promethazine hydrochloride is commonly used to treat allergic disorders, nausea, vomiting and difficulty sleeping, as well as for pre-operative sedation.
 
The FDA classified the recall as Class II, which means use of or exposure to the recalled products may cause temporary or medically reversible adverse health consequences.
 
The bottles being recalled carry an expiration date of September 2015, according to the FDA post.
 
"This was a voluntary recall by the company as a precautionary measure," a Zydus spokeswoman said in an email to Reuters.
 
Recalls of drugs are not uncommon.
 
However, Zydus's drug recall is the seventh this year by an Indian company, and follows those by other large drugmakers including Wockhardt Ltd, Ranbaxy Laboratories Ltd, Dr. Reddy's Laboratories Ltd, Lupin Ltd, Sun Pharmaceutical Industries Ltd and Glenmark Pharmaceuticals Ltd.
 
The incidents come at a time when the FDA has increased its scrutiny of Indian drugmakers after the agency banned exports from manufacturing plants of some top drugmakers, including Ranbaxy and Wockhardt, upon finding quality control lapses.
 

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Plant-Based Vaccines Challenge Big Pharma Dominance

Wednesday, 01 Oct 2014 08:07 AM

Two tiny companies are preparing to challenge some of the world's largest drugmakers in the battle for dominance in the  . . .

Irritable Bowel Drug Shows Promise in Trial

Wednesday, 01 Oct 2014 07:57 AM

Ardelyx Inc. said its experimental drug to treat constipation-related irritable bowel syndrome achieved the main goal of . . .

Ebola in the US: What You Need to Know

Wednesday, 01 Oct 2014 07:50 AM

U.S. health officials have warned for months that someone infected with Ebola could unknowingly carry the virus to this  . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved